95 related articles for article (PubMed ID: 15816204)
1. Progressive decrease of proinsulin secretion in sulphonylurea-treated type 2 diabetes.
Chen YN; Chen SY; Zeng LJ; Ran JM; Wu MY
Br J Biomed Sci; 2005; 62(1):5-8. PubMed ID: 15816204
[TBL] [Abstract][Full Text] [Related]
2. Secondary sulphonylurea failure: what pathogenesis is responsible?
Chen YN; Chen SY; Zeng LJ; Ran JM; Xie B; Wu MY; Wu YZ
Br J Biomed Sci; 2003; 60(1):9-13. PubMed ID: 12680624
[TBL] [Abstract][Full Text] [Related]
3. In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment.
Pscherer S; Larbig M; von Stritsky B; Pfützner A; Forst T
J Diabetes Sci Technol; 2012 May; 6(3):634-40. PubMed ID: 22768894
[TBL] [Abstract][Full Text] [Related]
4. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.
Wegner M; Winiarska H; Bobkiewicz-Kozłowska T; Dworacka M
Cytokine; 2008 Jun; 42(3):312-6. PubMed ID: 18397831
[TBL] [Abstract][Full Text] [Related]
5. The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.
Ohkura T; Inoue K; Fujioka Y; Nakanishi R; Shiochi H; Sumi K; Yamamoto N; Matsuzawa K; Izawa S; Ohkura H; Kato M; Yamamoto K; Taniguchi S
BMC Res Notes; 2013 Nov; 6():453. PubMed ID: 24215809
[TBL] [Abstract][Full Text] [Related]
6. Elevated ratio of summed serum proinsulin to insulin response after oral glucose load in type 2 diabetes decreases following sulfonylurea treatment.
Kumakura S; Iwamoto Y; Kuzuya T; Shiraishi I; Matsuda A; Saito T
Diabetes Res Clin Pract; 1995 Aug; 29(2):107-12. PubMed ID: 8591697
[TBL] [Abstract][Full Text] [Related]
7. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
8. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
Forst T; Anastassiadis E; Diessel S; Löffler A; Pfützner A
Diabetes Metab Res Rev; 2014 Oct; 30(7):582-9. PubMed ID: 24459063
[TBL] [Abstract][Full Text] [Related]
9. Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea.
Dworacka M; Abramczyk M; Winiarska H; Kuczynski S; Borowska M; Szczawinska K
Int J Clin Pharmacol Ther; 2006 Jan; 44(1):14-21. PubMed ID: 16425966
[TBL] [Abstract][Full Text] [Related]
10. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.
Abbink EJ; van der Wal PS; Sweep CG; Smits P; Tack CJ
Diabetes Metab Res Rev; 2004; 20(6):466-71. PubMed ID: 15386823
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of pancreatic beta-cell secretion in Type 2 diabetic patients treated with gliclazide and glibenclamide.
van der Wal PS; Heine RJ
Diabetes Res Clin Pract; 2001 May; 52(2):103-11. PubMed ID: 11311964
[TBL] [Abstract][Full Text] [Related]
12. The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus.
Pfützner A; Lorra B; Abdollahnia MR; Kann PH; Mathieu D; Pehnert C; Oligschleger C; Kaiser M; Forst T
Diabetes Technol Ther; 2006 Jun; 8(3):375-84. PubMed ID: 16800759
[TBL] [Abstract][Full Text] [Related]
13. Effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus.
Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
Diabet Med; 1994 Apr; 11(3):293-8. PubMed ID: 8033529
[TBL] [Abstract][Full Text] [Related]
14. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
[TBL] [Abstract][Full Text] [Related]
15. Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes.
Vauhkonen IK; Niskanen LK; Mykkänen L; Haffner SM; Uusitupa MI; Laakso M
Eur J Endocrinol; 2000 Aug; 143(2):251-60. PubMed ID: 10913945
[TBL] [Abstract][Full Text] [Related]
16. Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim study.
Pfützner A; Derwahl M; Jacob S; Hohberg C; Blümner E; Lehmann U; Fuchs W; Forst T
Diabetes Technol Ther; 2010 Aug; 12(8):599-604. PubMed ID: 20615100
[TBL] [Abstract][Full Text] [Related]
17. Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes.
Hermann LS; Ranstam J; Vaaler S; Melander A
Diabetes Obes Metab; 1999 Jul; 1(4):227-32. PubMed ID: 11228758
[TBL] [Abstract][Full Text] [Related]
18. The effect of gliclazide on plasma insulin, intact and 32/33 split proinsulin in South Asian subjects with Type 2 diabetes mellitus.
Ammari F; Davies MJ; Koppiker N; Gregory R; Burden AC
Diabet Med; 1999 Feb; 16(2):142-6. PubMed ID: 10229308
[TBL] [Abstract][Full Text] [Related]
19. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
